ATE172738T1 - Substituierte 6-aza-androstenone - Google Patents

Substituierte 6-aza-androstenone

Info

Publication number
ATE172738T1
ATE172738T1 AT94906449T AT94906449T ATE172738T1 AT E172738 T1 ATE172738 T1 AT E172738T1 AT 94906449 T AT94906449 T AT 94906449T AT 94906449 T AT94906449 T AT 94906449T AT E172738 T1 ATE172738 T1 AT E172738T1
Authority
AT
Austria
Prior art keywords
androstenone
aza
substituted
Prior art date
Application number
AT94906449T
Other languages
English (en)
Inventor
Robert Carl Andrews
Cynthia Markert Cribbs
Stephen Vernon Frye
Curt Dale Haffner
Patrick Reed Maloney
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ATE172738T1 publication Critical patent/ATE172738T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT94906449T 1992-12-18 1993-12-17 Substituierte 6-aza-androstenone ATE172738T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99393092A 1992-12-18 1992-12-18
US8066593A 1993-06-18 1993-06-18

Publications (1)

Publication Number Publication Date
ATE172738T1 true ATE172738T1 (de) 1998-11-15

Family

ID=26763785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906449T ATE172738T1 (de) 1992-12-18 1993-12-17 Substituierte 6-aza-androstenone

Country Status (24)

Country Link
EP (1) EP0674651B1 (de)
JP (1) JPH08504825A (de)
CN (1) CN1095383A (de)
AP (1) AP459A (de)
AT (1) ATE172738T1 (de)
AU (1) AU673899B2 (de)
BG (1) BG99729A (de)
CA (1) CA2152053A1 (de)
CZ (1) CZ157695A3 (de)
DE (1) DE69321849D1 (de)
FI (1) FI953009A7 (de)
HU (1) HUT72083A (de)
IL (1) IL108073A0 (de)
IS (1) IS4106A (de)
LV (1) LV10958B (de)
MX (1) MX9308015A (de)
NO (1) NO952402L (de)
NZ (1) NZ261415A (de)
OA (1) OA10167A (de)
PL (1) PL314532A1 (de)
SI (1) SI9300665A (de)
SK (1) SK79495A3 (de)
TW (1) TW293824B (de)
WO (1) WO1994014833A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5516779A (en) * 1994-06-08 1996-05-14 Merck & Co., Inc. 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors
US5817818A (en) * 1994-09-16 1998-10-06 Glaxo Wellcome Inc. Androstenones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
GB9506678D0 (en) * 1995-03-31 1995-05-24 Glaxo Inc Substituted 6-azacholesten-3-ones
WO1997014418A1 (en) * 1995-10-19 1997-04-24 Merck & Co., Inc. 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors
US5935968A (en) * 1997-03-17 1999-08-10 Merck & Co., Inc. Methods for treating polycystic ovary syndrome
CN1805915A (zh) 2003-04-15 2006-07-19 茵弗莱采姆药物有限公司 作为药物活性剂的茚衍生物
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US10100056B2 (en) 2013-03-14 2018-10-16 Aquinox Pharmaceuticals (Canada) Inc. SHIP1 modulators and methods related thereto
EP2970122B1 (de) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1-modulatoren
EP3313811A1 (de) 2015-06-26 2018-05-02 Aquinox Pharmaceuticals (Canada) Inc. Kristalline feste formen des acetatsalzes von (1s,3s,4r)-4- ((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methylenoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
BR112018072255B1 (pt) * 2016-04-29 2024-02-06 The Research Foundation For The State University Of New York Azasteroides para tratamento de tuberculose
EP4284804A1 (de) 2021-01-26 2023-12-06 Schrödinger, Inc. Tricyclische verbindungen zur behandlung von krebs, autoimmun- und entzündungserkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07502511A (ja) * 1991-12-20 1995-03-16 グラクソ、インコーポレーテッド 5‐α‐テストステロンレダクターゼ阻害剤
US5438061A (en) * 1993-07-16 1995-08-01 Merck & Co., Inc. 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors

Also Published As

Publication number Publication date
FI953009A0 (fi) 1995-06-16
AU673899B2 (en) 1996-11-28
LV10958A (lv) 1995-12-20
JPH08504825A (ja) 1996-05-28
EP0674651B1 (de) 1998-10-28
CA2152053A1 (en) 1994-07-07
AP459A (en) 1996-02-14
NZ261415A (en) 1997-03-24
AU6015094A (en) 1994-07-19
PL314532A1 (en) 1996-09-16
SK79495A3 (en) 1995-11-08
NO952402L (no) 1995-08-16
AP9300599A0 (en) 1994-01-31
WO1994014833A2 (en) 1994-07-07
BG99729A (bg) 1996-01-31
HUT72083A (en) 1996-03-28
FI953009L (fi) 1995-08-15
CZ157695A3 (en) 1995-12-13
LV10958B (en) 1996-10-20
NO952402D0 (no) 1995-06-16
OA10167A (en) 1996-12-18
DE69321849D1 (de) 1998-12-03
FI953009A7 (fi) 1995-08-15
WO1994014833A3 (en) 1994-09-29
IL108073A0 (en) 1994-04-12
HU9501775D0 (en) 1995-08-28
MX9308015A (es) 1994-08-31
IS4106A (is) 1994-06-19
TW293824B (de) 1996-12-21
CN1095383A (zh) 1994-11-23
SI9300665A (en) 1994-06-30
EP0674651A1 (de) 1995-10-04

Similar Documents

Publication Publication Date Title
FI933399L (fi) Deoxitaxoler
AT399443B (de) Sportschuh
FI953009A7 (fi) Substituoituja 6-atsa-androstenoneja
FI952804A0 (fi) Substituoidut bentsatsepinonit
BR9305745A (pt) Quebra-luz
FI931235L (fi) Foerbaettrad avslutningsanordning foer stumkopplingskablar
ATA236892A (de) Rotornut
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
FI932693A7 (fi) Saogtandoscillator
BR9301712A (pt) Aplainador
ATA227792A (de) Sportschuh
DE59310082D1 (de) Substituierte 2-arylpyrrole
FI441U1 (fi) Spaenningsregulator
BR7200240U (pt) Vari-watt
BR9200298A (pt) Microsisten-telesupervisao
BR9200554A (pt) Lixoduto
SE9200306D0 (sv) Hoejdstaellbart moebelbenlaas
BR9204368A (pt) Auto-coletor
BR9204074A (pt) Contramarco pre-moldano
BR9202723A (pt) Pipex
BR9203234A (pt) Sofa-mesa
NO175196C (no) Snuanordning
BR9201723A (pt) Filatorio
BR7200229U (pt) Doca-dupla
FIU920404U0 (fi) Bullerstaengselkonstruktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties